Odyssey Therapeutics

IPO

Transforming the standard of care

Odyssey Therapeutics is a biotech company in Boston, United States, founded in 2021. It has raised $700.0M across 4 rounds, most recently a $213.0M Series D in September 2025.

Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$700.0M
Last Round
$213.0M Series DSep 2025
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 10 investors for this company. to use credits for reveals, or explore the API.

About

Odyssey Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule and protein therapeutics for autoimmune and inflammatory diseases. Founded in 2021 and based in Boston, Odyssey uses a replicable and scalable drug discovery model combining AI-driven small molecule design with precision targeting of the innate immune system. The company has raised over $400 million across multiple financing rounds including a $213 million Series D in 2025.

Funding & Exit History

Data from Indexed.vcUpdated
IPOMay 2026
$279.0M

4 more events

  • Series D20256 investors
  • Series C20235 investors
  • Series B20221 investor

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×4
  • Cloud/Infrastructure ×1
  • HR & Finance ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Odyssey Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/odyssey-therapeutics"><img src="https://indexed.vc/api/badge/company/odyssey-therapeutics" alt="Odyssey Therapeutics on Indexed.vc" width="260" height="76" /></a>